ASCO: GSK Confident In DREAMM Of Returning Blenrep To Market

DREAMM-8 Trial Is Second Trial Supporting Second-Line Use

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.